GR3025770T3 - Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same. - Google Patents

Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same.

Info

Publication number
GR3025770T3
GR3025770T3 GR970403421T GR970403421T GR3025770T3 GR 3025770 T3 GR3025770 T3 GR 3025770T3 GR 970403421 T GR970403421 T GR 970403421T GR 970403421 T GR970403421 T GR 970403421T GR 3025770 T3 GR3025770 T3 GR 3025770T3
Authority
GR
Greece
Prior art keywords
same
pct
meso
complex compounds
preparing
Prior art date
Application number
GR970403421T
Other languages
English (en)
Inventor
Franz Karl Maier
Wolfgang Ebert
Mary Lee-Vaupel
Heinz Gries
Juergen Conrad
Original Assignee
Diagnostikforschung Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostikforschung Inst filed Critical Diagnostikforschung Inst
Publication of GR3025770T3 publication Critical patent/GR3025770T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR970403421T 1993-02-17 1997-12-23 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same. GR3025770T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4305523A DE4305523A1 (de) 1993-02-17 1993-02-17 Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
PCT/DE1994/000159 WO1994019352A1 (de) 1993-02-17 1994-02-11 Meso-tetraphenylporphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Publications (1)

Publication Number Publication Date
GR3025770T3 true GR3025770T3 (en) 1998-03-31

Family

ID=6481125

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403421T GR3025770T3 (en) 1993-02-17 1997-12-23 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same.

Country Status (11)

Country Link
US (1) US5674467A (el)
EP (1) EP0684948B1 (el)
JP (1) JPH08506819A (el)
AT (1) ATE159526T1 (el)
CA (1) CA2156158A1 (el)
DE (2) DE4305523A1 (el)
DK (1) DK0684948T3 (el)
ES (1) ES2110735T3 (el)
GR (1) GR3025770T3 (el)
NO (1) NO953220L (el)
WO (1) WO1994019352A1 (el)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
EP0758907A1 (en) * 1994-05-11 1997-02-26 Schering Aktiengesellschaft The use of porphyrin-complex or expanded porphyrin-complex compounds as localization diagnosticum for infarction or necrosis
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
US5883246A (en) * 1996-03-07 1999-03-16 Qlt Phototherapeutics, Inc. Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
WO2000000204A1 (en) 1997-02-14 2000-01-06 Miravant Pharmaceuticals, Inc. Indium photosensitizers for pdt
WO1999023097A1 (en) 1997-11-03 1999-05-14 Duke University Substituted porphyrins
DE19824653A1 (de) * 1998-02-25 1999-08-26 Schering Ag Nekrose-affine Verbindungen und ihre Verwendung zur Herstellung von Präparaten zur Pharmakotherapie
CA2329751C (en) * 1998-04-24 2010-10-12 Duke University Substituted porphyrins
CA2341507C (en) 1998-08-28 2011-05-24 William Guy Love Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
DK1155019T3 (da) 1999-01-25 2006-04-18 Nat Jewish Med & Res Center Substituerede porphyriner og deres terapeutiske anvendelse
WO2000052012A2 (en) 1999-03-05 2000-09-08 Emory University A method for synthesizing porphyrin compounds
US6376664B1 (en) * 1999-03-17 2002-04-23 The Ohio State University Cyclic bis-benzimidazole ligands and metal complexes thereof
US6403788B1 (en) 2000-07-11 2002-06-11 Eukarion, Inc. Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
JP4678661B2 (ja) * 2000-12-04 2011-04-27 日本化薬株式会社 新規なテトラキスアミノフェニル（ジ）フェニレンジアミン骨格を有する化合物
DE60233317D1 (de) * 2001-01-19 2009-09-24 Nat Jewish Med & Res Center Medikament zum schutz in der radiotherapie
US7048907B2 (en) * 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
EP1439842A4 (en) * 2001-06-01 2009-09-02 Nat Jewish Med & Res Center OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
US6566517B2 (en) 2001-06-06 2003-05-20 Brookhaven Science Associates, Llc Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
IL147898A (en) * 2002-01-30 2007-05-15 Yuval Golan A method of treating cancer based on the Ugar effect
AU2003237500A1 (en) * 2002-06-07 2003-12-22 Duke University Substituted porphyrins
ES2321930T3 (es) * 2002-12-20 2009-06-15 Centre National De La Recherche Scientifique Derivados de las porfirinas, sus procedimientos de obtencion, y sus usos en radioinmunoterapia.
FR2849035B1 (fr) * 2002-12-20 2005-05-20 Derives des porphyrines, leurs procedes d'obtention, et leurs utilisations en radioimmunotherapie
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US6989443B2 (en) * 2004-06-28 2006-01-24 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
IL181126A0 (en) * 2006-11-01 2007-07-04 S B Biotechnologies Ltd Preparation of gold-containing nano-liposome particles and their use in medical therapy
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
US20080279781A1 (en) * 2007-05-10 2008-11-13 Brookhaven Science Associates, Llc Glycosylated Carboranylporphyrins and Uses Thereof
ES2600469T3 (es) 2008-05-23 2017-02-09 National Jewish Health Un compuesto para su uso en el tratamiento de lesiones asociadas con la exposición al gas fosgeno o al gas de cloro
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
CN102260269B (zh) * 2010-05-25 2013-11-06 苏州和健医药科技有限公司 一种含有卟啉或二氢卟吩的树状化合物及其应用
CN102408430B (zh) * 2011-09-07 2013-11-06 沅江华龙催化科技有限公司 取代四苯基双铁卟啉的合成工艺与专用设备
CN113754672B (zh) * 2021-10-27 2024-05-03 上海先辉医药科技有限公司 一类新型四吡咯化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
DE3809671A1 (de) * 1988-03-18 1989-09-28 Schering Ag Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging

Also Published As

Publication number Publication date
DK0684948T3 (da) 1998-07-20
WO1994019352A1 (de) 1994-09-01
CA2156158A1 (en) 1994-09-01
EP0684948B1 (de) 1997-10-22
NO953220D0 (no) 1995-08-16
DE59404433D1 (de) 1997-11-27
NO953220L (no) 1995-10-16
DE4305523A1 (de) 1994-08-18
ATE159526T1 (de) 1997-11-15
JPH08506819A (ja) 1996-07-23
EP0684948A1 (de) 1995-12-06
US5674467A (en) 1997-10-07
ES2110735T3 (es) 1998-02-16

Similar Documents

Publication Publication Date Title
GR3025770T3 (en) Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same.
ATE175201T1 (de) Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
PL324890A1 (en) Halogenbenzimidazoles and their application as microbicides
DE10075007I2 (de) 1,4,7,10-Tetraazacyclododecan-butyltriole Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
NO308076B1 (no) Azadioksacykloalkener, fungicidmiddel inneholdende disse, anvendelse for fremstilling av fungicide midler, samt mellomprodukter
GR3017586T3 (en) Complex porphyrine compounds substituted in position 13,17 by propionic acid and propionic-acid derivatives, process for their preparation and pharmaceutical compositions containing same.
ATE172958T1 (de) 4-amino-fluorobenzamid und deren verwendung als cytotoxische prodrugs
ATE226953T1 (de) 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel und verfahren zu ihrer herstellung
AU2797695A (en) Thiazolidine derivatives, their preparation and drugs containing same
ATE90088T1 (de) 1-chlorpyrimidinyl-1h-1,2,4-triazol-3sulfons|ureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung.
ZA961395B (en) Metal complexes suitable for use in diagnosis and therapy
SE9103110D0 (sv) New drug formulation
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
WO1996040760A3 (en) Iodine-containing peptides and their use as x-ray contrast media
NO970140L (no) Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene
DE59409645D1 (en) Substituierte arylthioalkylthiopyridine
IL114239A0 (en) Pyrrolidine derivatives their preparation and com¦ositions containing them
KR960700223A (ko) C-치환 디에틸렌 트리아민의 제조 방법(Process for the Production of C-Substituted Diethylenetriamines)
DE59504077D1 (de) Neue 2.4-diphosphonoglutarsäurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel